Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1984 Dec;81(23):7293–7297. doi: 10.1073/pnas.81.23.7293

In vivo modulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase, reductase kinase, and reductase kinase kinase by mevalonolactone.

Z H Beg, J A Stonik, H B Brewer Jr
PMCID: PMC392132  PMID: 6594693

Abstract

It has been previously demonstrated that the enzymic activity of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase; EC 1.1.1.34) is modulated in vitro and in vivo by a bicyclic cascade system involving reversible phosphorylation of HMG-CoA reductase and reductase kinase. In the present study, administration of mevalonolactone to rats caused a rapid inhibition of HMG-CoA reductase activity. The initial short-term (20-min) reversible inhibition (38%) of enzyme activity was due to increased phosphorylation of HMG-CoA reductase. The inhibition of HMG-CoA reductase activity by increased phosphorylation was associated with an increased activity and phosphorylation (2- to 3-fold) of reductase kinase. The increased phosphorylation of reductase kinase was catalyzed by reductase kinase kinase, which was significantly elevated (3- to 4-fold) after the administration of mevalonolactone to rats. The mechanism for the in vivo activation of reductase kinase kinase is as yet unknown. Mevalonolactone administration was also associated with a significant inhibition of phosphoprotein phosphatase activity, which dephosphorylates both HMG-CoA reductase (activation) and reductase kinase (inactivation). These results indicate that mevalonolactone administration to rats in vivo was associated with an inhibition of HMG-CoA reductase activity by two mechanisms: (i) an increase in the degree of phosphorylation of both HMG-CoA reductase and reductase kinase due to increased activity of reductase kinase kinase; (ii) a decrease in the dephosphorylation of both HMG-CoA reductase and reductase kinase secondary to inhibition of phosphoprotein phosphatase activity. These combined effects favor an increase in the steady-state level of the phosphorylated forms of both HMG-CoA reductase and reductase kinase, resulting in a net reduction in the enzymic activity of HMG-CoA reductase and mevalonate formation. These results demonstrate that the activity of reductase kinase kinase is modulated in vivo, providing a mechanism for the regulation of the activities of both reductase kinase and HMG-CoA reductase.

Full text

PDF
7293

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arebalo R. E., Hardgrave J. E., Noland B. J., Scallen T. J. In vivo regulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase: enzyme phosphorylation as an early regulatory response after intragastric administration of mevalonolactone. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6429–6433. doi: 10.1073/pnas.77.11.6429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beg Z. H., Brewer H. B., Jr Modulation of rat liver 3-hydroxy-3-methylglutaryl-CoA reductase activity by reversible phosphorylation. Fed Proc. 1982 Aug;41(10):2634–2638. [PubMed] [Google Scholar]
  3. Beg Z. H., Brewer H. B., Jr Regulation of liver 3-hydroxy-3-methylglutaryl-CoA reductase. Curr Top Cell Regul. 1981;20:139–184. doi: 10.1016/b978-0-12-152820-1.50008-0. [DOI] [PubMed] [Google Scholar]
  4. Beg Z. H., Stonik J. A., Brewer H. B., Jr Human hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: evidence for the regulation of enzymic activity by a bicyclic phosphorylation cascade. Biochem Biophys Res Commun. 1984 Mar 15;119(2):488–498. doi: 10.1016/s0006-291x(84)80275-2. [DOI] [PubMed] [Google Scholar]
  5. Beg Z. H., Stonik J. A., Brewer H. B., Jr In vitro and in vivo phosphorylation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase and its modulation by glucagon. J Biol Chem. 1980 Sep 25;255(18):8541–8545. [PubMed] [Google Scholar]
  6. Beg Z. H., Stonik J. A. Reversible inactivation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: reductase kinase and mevalonate kinase are separate enzymes. Biochem Biophys Res Commun. 1982 Sep 30;108(2):559–566. doi: 10.1016/0006-291x(82)90865-8. [DOI] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  8. Brandt H., Capulong Z. L., Lee E. Y. Purification and properties of rabbit liver phosphorylase phosphatase. J Biol Chem. 1975 Oct 25;250(20):8038–8044. [PubMed] [Google Scholar]
  9. Cohen P. The role of cyclic-AMP-dependent protein kinase in the regulation of glycogen metabolism in mammalian skeletal muscle. Curr Top Cell Regul. 1978;14:117–196. doi: 10.1016/b978-0-12-152814-0.50008-3. [DOI] [PubMed] [Google Scholar]
  10. Edwards P. A., Lan S. F., Tanaka R. D., Fogelman A. M. Mevalonolactone inhibits the rate of synthesis and enhances the rate of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat hepatocytes. J Biol Chem. 1983 Jun 25;258(12):7272–7275. [PubMed] [Google Scholar]
  11. Erickson S. K., Shrewsbury M. A., Gould R. G., Cooper A. D. Studies on the mechanisms of the rapid modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in intact liver by mevalonolactone and 25-hydroxycholesterol. Biochim Biophys Acta. 1980 Oct 6;620(1):70–79. doi: 10.1016/0005-2760(80)90186-1. [DOI] [PubMed] [Google Scholar]
  12. Goris J., Defreyn G., Vandenheede J. R., Merlevede W. Protein inhibitors of dog-liver phosphorylase phosphatase dependent on and independent of protein kinase. Eur J Biochem. 1978 Nov 15;91(2):457–464. doi: 10.1111/j.1432-1033.1978.tb12698.x. [DOI] [PubMed] [Google Scholar]
  13. Huang F. L., Glinsmann W. H. Inactivation of rabbit muscle phosphorylase phosphatase by cyclic AMP-dependent kinas. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3004–3008. doi: 10.1073/pnas.72.8.3004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ingebritsen T. S., Geelen M. J., Parker R. A., Evenson K. J., Gibson D. M. Modulation of hydroxymethylglutaryl-CoA reductase activity, reductase kinase activity, and cholesterol synthesis in rat hepatocytes in response to insulin and glucagon. J Biol Chem. 1979 Oct 25;254(20):9986–9989. [PubMed] [Google Scholar]
  15. Khandelwal R. L., Zinman S. M., Zebrowski E. J. The effect of streptozotocin-induced diabetes and of insulin supplementation on glycogen metabolism in rat liver. Biochem J. 1977 Dec 15;168(3):541–548. doi: 10.1042/bj1680541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nordstrom J. L., Rodwell V. W., Mitschelen J. J. Interconversion of active and inactive forms of rat liver hydroxymethylglutaryl-CoA reductase. J Biol Chem. 1977 Dec 25;252(24):8924–8934. [PubMed] [Google Scholar]
  17. Rodwell V. W., Nordstrom J. L., Mitschelen J. J. Regulation of HMG-CoA reductase. Adv Lipid Res. 1976;14:1–74. doi: 10.1016/b978-0-12-024914-5.50008-5. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES